Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19
Rachel A. Bender Ignacio,Kara W. Chew,Carlee Moser,Judith S. Currier,Joseph J. Eron,Arzhang Cyrus Javan,Mark J. Giganti,Evgenia Aga,Michael Gibbs, Hervé Tchouakam Kouekam,Eva Johnsson,Mark T. Esser,Keila Hoover,Gene Neytman,Matthew Newell,Eric S. Daar,William A. Fischer,Courtney V. Fletcher,Jonathan Z. Li,Alexander L. Greninger,Robert W. Coombs,Michael D. Hughes,Davey M Smith,David A. Wohl,Justin Ritz,Lara Hosey,Jhoanna Roa, Nilam Patel, Kelly Colsh, Irene Rwakazina, Justine Beck,Scott F. Sieg,Teresa H. Evering,Sandra Wagner Cardoso,Katya Corado,Prasanna Jagannathan,Nikolaus Jilg,Alan S. Perelson,Sandy Pillay,Cynthia Riviere,Upinder Singh, Babafenu Taiwo, Joan Gottesman,Susan Pedersen,Cheryl Jennings, Brian Greenfelder,William Murtaugh, Jan Kosmyna, Morgan Gapara, Akbar Shahkolahi,Robert A. Gasser JAMA network open（2023）
关键词
combined tixagevimab,cilgavimab,nonhospitalized patients
AI 理解论文
溯源树
样例
